each month having redemption or exercise; (2) the report of the exercising right to purchase underlying shares of warrants, shall be submitted by using form 81-2 as provided on the website of the SEC

reduction of 89,200,714 unissued shares of the Company at a par value of Baht 1.00 per share, reserved for the exercise of warrants to purchase ordinary shares no. 1, issued and offered to the existing

with higher administrative expenses. 4 (Unit: Baht million) Consolidated balance sheets As at 31st Mar 2019 As at 31st Mar 2018 Amount % Amount % Assets Current Assets Cash and cash equivalents 314.32

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

-Translation- UAC.CS/005/2019 April 2, 2019 Subject: The acquisition of assets of UAC Energy Co., Ltd. (Subsidiary) by investment in waste management project to produce renewable energy and process

which occurred on mid of 2019 for projects’ working capital. Statement of Financial Position (Unit: Million Baht) Details 31 Mar 2020 31 Dec 2019 Increased (Decreased) % Assets Current assets Cash and

impairment of intangible assets - - 16.87 28.57 Loss from impairment finance costs and share of loss from associates 29.81 216.80 - - Doubtful Account 88.24 641.75 - - Loss from impairment of goodwill 51.20

Mar 2017 Amount % Amount % Assets Current Assets Cash and cash equivalents 237.54 10.37% 237.45 10.45% Short-term investment 3.73 0.16% 21.35 0.94% Account receivable, trade and others 728.08 31.80

decreased by 52.5% compared with QoQ. Statements of Financial Position as at March 31, 2018 March 31, 2018 (Million Baht) December 31, 2017 (Million Baht) Change (%) Current Assets 1,280.7 1,230.2 4.1 Non

was mainly from the higher in gross margin. 4 (Unit: Baht million) Consolidated balance sheets As at 31st Mar 2018 As at 31st Mar 2017 Amount % Amount % Assets Current Assets Cash and cash equivalents